Home > Insider Trading > Filing (0001209191-15-080796)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1479290	Revance Therapeutics Inc.	RVNC	Pharmaceutical Preparations (2834)	770551645

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1426344	Peter Arthur Bertolino	C/O Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark CA 94560	Evp And Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-11-17	5,425	$39.11	36,329	No	4	S	Direct
Common Stock	Disposition	2015-11-17	36	$39.55	36,293	No	4	S	Direct
Common Stock	Disposition	2015-11-17	2,277	$39.11	34,016	No	4	S	Direct
Common Stock	Disposition	2015-11-17	15	$39.55	34,001	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The Reporting Person sold an aggregate of 5,461 shares of restricted stock to settle a personal tax liability in connection with the November 15, 2015 vesting of certain shares of restricted stock that the Reporting Person acquired pursuant to a grant dated September 2, 2014.
The Reporting Person sold an aggregate of 2,292 shares of restricted stock to settle a personal tax liability in connection with the November 15, 2015 vesting of certain shares of restricted stock that the Reporting Person acquired pursuant to a grant dated January 28, 2015.